SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-21-017951
Filing Date
2021-07-29
Accepted
2021-07-29 21:33:50
Documents
1
Period of Report
2021-07-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3676
  Complete submission text file 0001437749-21-017951.txt   5129
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Cytocom, Inc. (Issuer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2537 RESEARCH BOULEVARD SUITE 201 FORT COLLINS CO 80526
Business Address
McAvoy Cozette M. (Reporting) CIK: 0001846650 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32954 | Film No.: 211129732